Fluvastatin reduces pulmonary vein spontaneous activity through nitric oxide pathway

Yu Feng Hu, Yao Chang Chen, Chen Chuan Cheng, Satoshi Higa, Yi Jen Chen, Shih Ann Chen

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

HMG-CoA Reductase Inhibitors on Pulmonary Veins. Introduction: Pulmonary veins (PVs) are the most important focus for the generation of atrial fibrillation. The HMG-CoA reductase inhibitors (statins) can reduce the occurrence of atrial fibrillation. The purposes of this study were to evaluate whether statins may inhibit the PV arrhythmogenic activity to prevent atrial arrhythmias from PVs and to investigate the link between fluvastatin, nitric oxide synthase (NOS) activity, mechanical activity, and electrical activity. Methods: Conventional microelectrodes and Western blot were used to record the electrical activity, diastolic tension, contractility and expression of Akt, endothelial nitric oxide synthase (eNOS), neuronal nitric oxide synthase (nNOS), and phosphorylated Akt and eNOS before and after the administration of fluvastatin in rabbit PVs or atria. Results: Fluvastatin decreased the PV spontaneous activity, diastolic tension, and contractility, but did not change the action potential duration or resting membrane potential. The effects of fluvastatin on the PV firing rate and diastolic tension were attenuated in the presence of L-NAME (100 μM), wortmannin (100 nM), and ODQ (3 μM). Fluvastatin (1 μM) increased the phosphorylated Akt and eNOS, but did not change the total Akt or eNOS in the PVs and atria. In contrast, fluvastatin (1 μM) decreased the total nNOS in the PVs and atria. Conclusions and implications: Fluvastatin produced nitric oxide through the PI3kinase/Akt pathway, thus reducing the PV vascular diastolic tension and PV spontaneous activity. These results may contribute to the beneficial effects of statins.

Original languageEnglish
Pages (from-to)200-206
Number of pages7
JournalJournal of Cardiovascular Electrophysiology
Volume20
Issue number2
DOIs
Publication statusPublished - Feb 2009

Fingerprint

fluvastatin
Pulmonary Veins
Nitric Oxide
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Nitric Oxide Synthase Type III
Nitric Oxide Synthase Type I
Atrial Fibrillation

Keywords

  • Arrythmogenesis
  • Atrial fibrillation
  • Nitric oxide
  • Pulmonary veins
  • Statins

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Physiology (medical)

Cite this

Fluvastatin reduces pulmonary vein spontaneous activity through nitric oxide pathway. / Hu, Yu Feng; Chen, Yao Chang; Cheng, Chen Chuan; Higa, Satoshi; Chen, Yi Jen; Chen, Shih Ann.

In: Journal of Cardiovascular Electrophysiology, Vol. 20, No. 2, 02.2009, p. 200-206.

Research output: Contribution to journalArticle

Hu, Yu Feng ; Chen, Yao Chang ; Cheng, Chen Chuan ; Higa, Satoshi ; Chen, Yi Jen ; Chen, Shih Ann. / Fluvastatin reduces pulmonary vein spontaneous activity through nitric oxide pathway. In: Journal of Cardiovascular Electrophysiology. 2009 ; Vol. 20, No. 2. pp. 200-206.
@article{0aceab8542ac4702a704d64264fd8dd9,
title = "Fluvastatin reduces pulmonary vein spontaneous activity through nitric oxide pathway",
abstract = "HMG-CoA Reductase Inhibitors on Pulmonary Veins. Introduction: Pulmonary veins (PVs) are the most important focus for the generation of atrial fibrillation. The HMG-CoA reductase inhibitors (statins) can reduce the occurrence of atrial fibrillation. The purposes of this study were to evaluate whether statins may inhibit the PV arrhythmogenic activity to prevent atrial arrhythmias from PVs and to investigate the link between fluvastatin, nitric oxide synthase (NOS) activity, mechanical activity, and electrical activity. Methods: Conventional microelectrodes and Western blot were used to record the electrical activity, diastolic tension, contractility and expression of Akt, endothelial nitric oxide synthase (eNOS), neuronal nitric oxide synthase (nNOS), and phosphorylated Akt and eNOS before and after the administration of fluvastatin in rabbit PVs or atria. Results: Fluvastatin decreased the PV spontaneous activity, diastolic tension, and contractility, but did not change the action potential duration or resting membrane potential. The effects of fluvastatin on the PV firing rate and diastolic tension were attenuated in the presence of L-NAME (100 μM), wortmannin (100 nM), and ODQ (3 μM). Fluvastatin (1 μM) increased the phosphorylated Akt and eNOS, but did not change the total Akt or eNOS in the PVs and atria. In contrast, fluvastatin (1 μM) decreased the total nNOS in the PVs and atria. Conclusions and implications: Fluvastatin produced nitric oxide through the PI3kinase/Akt pathway, thus reducing the PV vascular diastolic tension and PV spontaneous activity. These results may contribute to the beneficial effects of statins.",
keywords = "Arrythmogenesis, Atrial fibrillation, Nitric oxide, Pulmonary veins, Statins",
author = "Hu, {Yu Feng} and Chen, {Yao Chang} and Cheng, {Chen Chuan} and Satoshi Higa and Chen, {Yi Jen} and Chen, {Shih Ann}",
year = "2009",
month = "2",
doi = "10.1111/j.1540-8167.2008.01281.x",
language = "English",
volume = "20",
pages = "200--206",
journal = "Journal of Cardiovascular Electrophysiology",
issn = "1045-3873",
publisher = "Wiley-Blackwell",
number = "2",

}

TY - JOUR

T1 - Fluvastatin reduces pulmonary vein spontaneous activity through nitric oxide pathway

AU - Hu, Yu Feng

AU - Chen, Yao Chang

AU - Cheng, Chen Chuan

AU - Higa, Satoshi

AU - Chen, Yi Jen

AU - Chen, Shih Ann

PY - 2009/2

Y1 - 2009/2

N2 - HMG-CoA Reductase Inhibitors on Pulmonary Veins. Introduction: Pulmonary veins (PVs) are the most important focus for the generation of atrial fibrillation. The HMG-CoA reductase inhibitors (statins) can reduce the occurrence of atrial fibrillation. The purposes of this study were to evaluate whether statins may inhibit the PV arrhythmogenic activity to prevent atrial arrhythmias from PVs and to investigate the link between fluvastatin, nitric oxide synthase (NOS) activity, mechanical activity, and electrical activity. Methods: Conventional microelectrodes and Western blot were used to record the electrical activity, diastolic tension, contractility and expression of Akt, endothelial nitric oxide synthase (eNOS), neuronal nitric oxide synthase (nNOS), and phosphorylated Akt and eNOS before and after the administration of fluvastatin in rabbit PVs or atria. Results: Fluvastatin decreased the PV spontaneous activity, diastolic tension, and contractility, but did not change the action potential duration or resting membrane potential. The effects of fluvastatin on the PV firing rate and diastolic tension were attenuated in the presence of L-NAME (100 μM), wortmannin (100 nM), and ODQ (3 μM). Fluvastatin (1 μM) increased the phosphorylated Akt and eNOS, but did not change the total Akt or eNOS in the PVs and atria. In contrast, fluvastatin (1 μM) decreased the total nNOS in the PVs and atria. Conclusions and implications: Fluvastatin produced nitric oxide through the PI3kinase/Akt pathway, thus reducing the PV vascular diastolic tension and PV spontaneous activity. These results may contribute to the beneficial effects of statins.

AB - HMG-CoA Reductase Inhibitors on Pulmonary Veins. Introduction: Pulmonary veins (PVs) are the most important focus for the generation of atrial fibrillation. The HMG-CoA reductase inhibitors (statins) can reduce the occurrence of atrial fibrillation. The purposes of this study were to evaluate whether statins may inhibit the PV arrhythmogenic activity to prevent atrial arrhythmias from PVs and to investigate the link between fluvastatin, nitric oxide synthase (NOS) activity, mechanical activity, and electrical activity. Methods: Conventional microelectrodes and Western blot were used to record the electrical activity, diastolic tension, contractility and expression of Akt, endothelial nitric oxide synthase (eNOS), neuronal nitric oxide synthase (nNOS), and phosphorylated Akt and eNOS before and after the administration of fluvastatin in rabbit PVs or atria. Results: Fluvastatin decreased the PV spontaneous activity, diastolic tension, and contractility, but did not change the action potential duration or resting membrane potential. The effects of fluvastatin on the PV firing rate and diastolic tension were attenuated in the presence of L-NAME (100 μM), wortmannin (100 nM), and ODQ (3 μM). Fluvastatin (1 μM) increased the phosphorylated Akt and eNOS, but did not change the total Akt or eNOS in the PVs and atria. In contrast, fluvastatin (1 μM) decreased the total nNOS in the PVs and atria. Conclusions and implications: Fluvastatin produced nitric oxide through the PI3kinase/Akt pathway, thus reducing the PV vascular diastolic tension and PV spontaneous activity. These results may contribute to the beneficial effects of statins.

KW - Arrythmogenesis

KW - Atrial fibrillation

KW - Nitric oxide

KW - Pulmonary veins

KW - Statins

UR - http://www.scopus.com/inward/record.url?scp=59149101723&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=59149101723&partnerID=8YFLogxK

U2 - 10.1111/j.1540-8167.2008.01281.x

DO - 10.1111/j.1540-8167.2008.01281.x

M3 - Article

VL - 20

SP - 200

EP - 206

JO - Journal of Cardiovascular Electrophysiology

JF - Journal of Cardiovascular Electrophysiology

SN - 1045-3873

IS - 2

ER -